Molecular Approaches to Identify Helicobacter pylori Antimicrobial Resistance

Gastroenterology Clinics of North America

Volumn 44, Issue 3, 2015, Pages 577-596

  Mégraud, Francis ^a   Bénéjat, Lucie ^a   Ontsira Ngoyi, Esther Nina ^a   Lehours, Philippe ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Dual priming oligonucleotide; Fluorescent in situ hybridization; Fluoroquinolones; Macrolides; Polymerase chain reaction; Real time polymerase chain reaction; Rifampins; Tetracyclines

Indexed keywords

5 NITROIMIDAZOLE DERIVATIVE; AMOXICILLIN; ANTIBIOTIC AGENT; BACTERIAL RNA; CLARITHROMYCIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; LEVOFLOXACIN; MACROLIDE; PEPTIDE NUCLEIC ACID; PROTON PUMP INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFABUTIN; RIFAMPICIN; RNA 23S; TETRACYCLINE; ANTIINFECTIVE AGENT; BACTERIAL DNA;

ALLELE SPECIFIC PRIMER POLYMERASE CHAIN REACTION; AMPLICON; ANALYTICAL EQUIPMENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM CULTURE; COLORIMETRY; DNA PROBE; DNA SEQUENCE; EPSILOMETER TEST; ERADICATION THERAPY; FLUORESCENCE IN SITU HYBRIDIZATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE MUTATION; GENOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INTERMETHOD COMPARISON; MEASUREMENT ACCURACY; MINIMUM INHIBITORY CONCENTRATION; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION SYSTEM; PRIMER MISMATCH POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; STANDARDIZATION; TEST STRIP; THERMOCYCLER; DRUG EFFECTS; GENETICS; HELICOBACTER INFECTIONS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MUTATION; POLYMERASE CHAIN REACTION; PROCEDURES;

ANTI-BACTERIAL AGENTS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MICROBIAL SENSITIVITY TESTS; MUTATION; POLYMERASE CHAIN REACTION;

EID: 84940453057     PISSN: 08898553     EISSN: 15581942     Source Type: Journal    
DOI: 10.1016/j.gtc.2015.05.002     Document Type: Review

References (83)

1. Megraud F., Lamouliatte H. Review article: the treatment of refractory Helicobacter pylori infection. Aliment Pharmacol Ther 2003, 17:1333-1343.
2. Megraud F. H. pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 2004, 53:1374-1384.
3. Malfertheiner P., Bazzoli F., Delchier J.C., et al. Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial. Lancet 2011, 377:905-913.
4. Versalovic J., Shortridge D., Kibler K., et al. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother 1996, 40:477-480.
5. Menard A., Santos A., Megraud F., et al. PCR-restriction fragment length polymorphism can also detect point mutation A2142C in the 23S rRNA gene, associated with Helicobacter pylori resistance to clarithromycin. Antimicrob Agents Chemother 2002, 46:1156-1157.
6. Burucoa C., Landron C., Garnier M., et al. T2182C mutation is not associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother 2005, 49:868. [author reply: 868-70].
7. De Francesco V., Zullo A., Giorgio F., et al. Change of point mutations in Helicobacter pylori rRNA associated with clarithromycin resistance in Italy. J Med Microbiol 2014, 63:453-457.
8. Mamelli L., Prouzet-Mauleon V., Pages J.M., et al. Molecular basis of macrolide resistance in Campylobacter: role of efflux pumps and target mutations. J Antimicrob Chemother 2005, 56:491-497.
9. Oleastro M., Menard A., Santos A., et al. Real-time PCR assay for rapid and accurate detection of point mutations conferring resistance to clarithromycin in Helicobacter pylori. J Clin Microbiol 2003, 41:397-402.
10. Matsumura M., Hikiba Y., Ogura K., et al. Rapid detection of mutations in the 23S rRNA gene of Helicobacter pylori that confers resistance to clarithromycin treatment to the bacterium. J Clin Microbiol 2001, 39:691-695.
11. Gibson J.R., Saunders N.A., Burke B., et al. Novel method for rapid determination of clarithromycin sensitivity in Helicobacter pylori. J Clin Microbiol 1999, 37:3746-3748.
12. Chisholm S.A., Owen R.J., Teare E.L., et al. PCR-based diagnosis of Helicobacter pylori infection and real-time determination of clarithromycin resistance directly from human gastric biopsy samples. J Clin Microbiol 2001, 39:1217-1220.
13. Schabereiter-Gurtner C., Hirschl A.M., Dragosics B., et al. Novel real-time PCR assay for detection of Helicobacter pylori infection and simultaneous clarithromycin susceptibility testing of stool and biopsy specimens. J Clin Microbiol 2004, 42:4512-4518.
14. Vecsei A., Innerhofer A., Binder C., et al. Stool polymerase chain reaction for Helicobacter pylori detection and clarithromycin susceptibility testing in children. Clin Gastroenterol Hepatol 2010, 8:309-312.
15. Lottspeich C., Schwarzer A., Panthel K., et al. Evaluation of the novel Helicobacter pylori ClariRes real-time PCR assay for detection and clarithromycin susceptibility testing of H. pylori in stool specimens from symptomatic children. J Clin Microbiol 2007, 45:1718-1722.
16. Makristathis A., Hirschl A.M., Russmann H., et al. Detection and clarithromycin susceptibility testing of Helicobacter pylori in stool specimens by real-time PCR: how to get accurate test results. J Clin Microbiol 2007, 45:2756. [author reply: 2756-7].
17. Lascols C., Lamarque D., Costa J.M., et al. Fast and accurate quantitative detection of Helicobacter pylori and identification of clarithromycin resistance mutations in H. pylori isolates from gastric biopsy specimens by real-time PCR. J Clin Microbiol 2003, 41:4573-4577.
18. De Francesco V., Margiotta M., Zullo A., et al. Primary clarithromycin resistance in Italy assessed on Helicobacter pylori DNA sequences by TaqMan real-time polymerase chain reaction. Aliment Pharmacol Ther 2006, 23:429-435.
19. Burucoa C., Garnier M., Silvain C., et al. Quadruplex real-time PCR assay using allele-specific scorpion primers for detection of mutations conferring clarithromycin resistance to Helicobacter pylori. J Clin Microbiol 2008, 46:2320-2326.
20. Cambau E., Allerheiligen V., Coulon C., et al. Evaluation of a new test, GenoType HelicoDR, for molecular detection of antibiotic resistance in Helicobacter pylori. J Clin Microbiol 2009, 47:3600-3607.
21. van Doorn L.J., Debets-Ossenkopp Y.J., Marais A., et al. Rapid detection, by PCR and reverse hybridization, of mutations in the Helicobacter pylori 23S rRNA gene, associated with macrolide resistance. Antimicrob Agents Chemother 1999, 43:1779-1782.
22. van der Ende A., van Doorn L.J., Rooijakkers S., et al. Clarithromycin-susceptible and -resistant Helicobacter pylori isolates with identical randomly amplified polymorphic DNA-PCR genotypes cultured from single gastric biopsy specimens prior to antibiotic therapy. J Clin Microbiol 2001, 39:2648-2651.
23. Chun J.Y., Kim K.J., Hwang I.T., et al. Dual priming oligonucleotide system for the multiplex detection of respiratory viruses and SNP genotyping of CYP2C19 gene. Nucleic Acids Res 2007, 35:e40.
24. Woo H.Y., Park D.I., Park H., et al. Dual-priming oligonucleotide-based multiplex PCR for the detection of Helicobacter pylori and determination of clarithromycin resistance with gastric biopsy specimens. Helicobacter 2009, 14:22-28.
25. Cho A.R., Lee M.K. A comparison analysis on the diagnosis of Helicobacter pylori infection and the detection of clarithromycin resistance according to biopsy sites. Korean J Lab Med 2010, 30:381-387. [in Korean].
26. Lehours P., Siffre E., Megraud F. DPO multiplex PCR as an alternative to culture and susceptibility testing to detect Helicobacter pylori and its resistance to clarithromycin. BMC Gastroenterol 2011, 11:112.
27. Noguchi N., Rimbara E., Kato A., et al. Detection of mixed clarithromycin-resistant and -susceptible Helicobacter pylori using nested PCR and direct sequencing of DNA extracted from faeces. J Med Microbiol 2007, 56:1174-1180.
28. Pina M., Occhialini A., Monteiro L., et al. Detection of point mutations associated with resistance of Helicobacter pylori to clarithromycin by hybridization in liquid phase. J Clin Microbiol 1998, 36:3285-3290.
29. Marais A., Monteiro L., Occhialini A., et al. Direct detection of Helicobacter pylori resistance to macrolides by a polymerase chain reaction/DNA enzyme immunoassay in gastric biopsy specimens. Gut 1999, 44:463-467.
30. Nickerson D.A., Kaiser R., Lappin S., et al. Automated DNA diagnostics using an ELISA-based oligonucleotide ligation assay. Proc Natl Acad Sci U S A 1990, 87:8923-8927.
31. Stone G.G., Shortridge D., Versalovic J., et al. A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori. Antimicrob Agents Chemother 1997, 41:712-714.
32. Maeda S., Yoshida H., Matsunaga H., et al. Detection of clarithromycin-resistant Helicobacter pylori strains by a preferential homoduplex formation assay. J Clin Microbiol 2000, 38:210-214.
33. Posteraro P., Branca G., Sanguinetti M., et al. Rapid detection of clarithromycin resistance in Helicobacter pylori using a PCR-based denaturing HPLC assay. J Antimicrob Chemother 2006, 57:71-78.
34. Trespalacios A.A., Rimbara E., Otero W., et al. Improved allele-specific PCR assays for detection of clarithromycin and fluoroquinolone resistant of Helicobacter pylori in gastric biopsies: identification of N87I mutation in GyrA. Diagn Microbiol Infect Dis 2015, 81(4):251-255.
35. Furuta T., Soya Y., Sugimoto M., et al. Modified allele-specific primer-polymerase chain reaction method for analysis of susceptibility of Helicobacter pylori strains to clarithromycin. J Gastroenterol Hepatol 2007, 22:1810-1815.
36. Ge Z., Taylor D.E. Rapid polymerase chain reaction screening of Helicobacter pylori chromosomal point mutations. Helicobacter 1997, 2:127-131.
37. Alarcon T., Domingo D., Prieto N., et al. PCR using 3'-mismatched primers to detect A2142C mutation in 23S rRNA conferring resistance to clarithromycin in Helicobacter pylori clinical isolates. J Clin Microbiol 2000, 38:923-925.
38. Pan Z.J., Su W.W., Tytgat G.N., et al. Assessment of clarithromycin-resistant Helicobacter pylori among patients in Shanghai and Guangzhou, China, by primer-mismatch PCR. J Clin Microbiol 2002, 40:259-261.
39. Elviss N.C., Lawson A.J., Owen R.J. Application of 3'-mismatched reverse primer PCR compared with real-time PCR and PCR-RFLP for the rapid detection of 23S rDNA mutations associated with clarithromycin resistance in Helicobacter pylori. Int J Antimicrob Agents 2004, 23:349-355.
40. Fors L., Lieder K.W., Vavra S.H., et al. Large-scale SNP scoring from unamplified genomic DNA. Pharmacogenomics 2000, 1:219-229.
41. Furuta T., Sagehashi Y., Shirai N., et al. Influence of CYP2C19 polymorphism and Helicobacter pylori genotype determined from gastric tissue samples on response to triple therapy for H pylori infection. Clin Gastroenterol Hepatol 2005, 3:564-573.
42. Trebesius K., Panthel K., Strobel S., et al. Rapid and specific detection of Helicobacter pylori macrolide resistance in gastric tissue by fluorescent in situ hybridisation. Gut 2000, 46:608-614.
43. Juttner S., Vieth M., Miehlke S., et al. Reliable detection of macrolide-resistant Helicobacter pylori via fluorescence in situ hybridization in formalin-fixed tissue. Mod Pathol 2004, 17:684-689.
44. Morris J.M., Reasonover A.L., Bruce M.G., et al. Evaluation of seaFAST, a rapid fluorescent in situ hybridization test, for detection of Helicobacter pylori and resistance to clarithromycin in paraffin-embedded biopsy sections. J Clin Microbiol 2005, 43:3494-3496.
45. Cerqueira L., Fernandes R.M., Ferreira R.M., et al. PNA-FISH as a new diagnostic method for the determination of clarithromycin resistance of Helicobacter pylori. BMC Microbiol 2011, 11:101.
46. Cerqueira L., Fernandes R.M., Ferreira R.M., et al. Validation of a fluorescence in situ hybridization method using peptide nucleic acid probes for detection of Helicobacter pylori clarithromycin resistance in gastric biopsy specimens. J Clin Microbiol 2013, 51:1887-1893.
47. Fontenete S., Guimaraes N., Leite M., et al. Hybridization-based detection of Helicobacter pylori at human body temperature using advanced locked nucleic acid (LNA) probes. PLoS One 2013, 8:e81230.
48. Xing J.Z., Clarke C., Zhu L., et al. Development of a microelectronic chip array for high-throughput genotyping of Helicobacter species and screening for antimicrobial resistance. J Biomol Screen 2005, 10:235-245.
49. Lapierre M.A., O'Keefe M., Taft B.J., et al. Electrocatalytic detection of pathogenic DNA sequences and antibiotic resistance markers. Anal Chem 2003, 75:6327-6333.
50. De Francesco V., Zullo A., Ierardi E., et al. Phenotypic and genotypic Helicobacter pylori clarithromycin resistance and therapeutic outcome: benefits and limits. J Antimicrob Chemother 2010, 65:327-332.
51. Monno R., Giorgio F., Carmine P., et al. Helicobacter pylori clarithromycin resistance detected by Etest and TaqMan real-time polymerase chain reaction: a comparative study. APMIS 2012, 120:712-717.
52. Liou J.M., Chang C.Y., Sheng W.H., et al. Genotypic resistance in Helicobacter pylori strains correlates with susceptibility test and treatment outcomes after levofloxacin- and clarithromycin-based therapies. Antimicrob Agents Chemother 2011, 55:1123-1129.
53. Francavilla R., Lionetti E., Castellaneta S., et al. Clarithromycin-resistant genotypes and eradication of Helicobacter pylori. J Pediatr 2010, 157:228-232.
54. Lee J.H., Shin J.H., Roe I.H., et al. Impact of clarithromycin resistance on eradication of Helicobacter pylori in infected adults. Antimicrob Agents Chemother 2005, 49:1600-1603.
55. Moore R.A., Beckthold B., Wong S., et al. Nucleotide sequence of the gyrA gene and characterization of ciprofloxacin-resistant mutants of Helicobacter pylori. Antimicrob Agents Chemother 1995, 39:107-111.
56. Tankovic J., Lascols C., Sculo Q., et al. Single and double mutations in gyrA but not in gyrB are associated with low- and high-level fluoroquinolone resistance in Helicobacter pylori. Antimicrob Agents Chemother 2003, 47:3942-3944.
57. Glocker E., Kist M. Rapid detection of point mutations in the gyrA gene of Helicobacter pylori conferring resistance to ciprofloxacin by a fluorescence resonance energy transfer-based real-time PCR approach. J Clin Microbiol 2004, 42:2241-2246.
58. Bogaerts P., Berhin C., Nizet H., et al. Prevalence and mechanisms of resistance to fluoroquinolones in Helicobacter pylori strains from patients living in Belgium. Helicobacter 2006, 11:441-445.
59. Cattoir V., Nectoux J., Lascols C., et al. Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility. Int J Antimicrob Agents 2007, 29:389-396.
60. Kese D., Gubina M., Kogoj R., et al. Detection of point mutations in the gyrA gene of Helicobacter pylori isolates in Slovenia. Hepatogastroenterology 2009, 56:925-929.
61. Wang L.H., Cheng H., Hu F.L., et al. Distribution of gyrA mutations in fluoroquinolone-resistant Helicobacter pylori strains. World J Gastroenterol 2010, 16:2272-2277.
62. Garcia M., Raymond J., Garnier M., et al. Distribution of spontaneous gyrA mutations in 97 fluoroquinolone-resistant Helicobacter pylori isolates collected in France. Antimicrob Agents Chemother 2012, 56:550-551.
63. Rimbara E., Noguchi N., Kawai T., et al. Fluoroquinolone resistance in Helicobacter pylori: role of mutations at position 87 and 91 of GyrA on the level of resistance and identification of a resistance conferring mutation in GyrB. Helicobacter 2012, 17:36-42.
64. Ontsira Ngoyi E.N., Atipo Ibara B.I., Moyen R., et al. Molecular detection of Helicobacter pylori and its antimicrobial resistance in Brazzaville, Congo. Helicobacter 2015, [Epub ahead of print].
65. Nishizawa T., Suzuki H., Umezawa A., et al. Rapid detection of point mutations conferring resistance to fluoroquinolone in gyrA of Helicobacter pylori by allele-specific PCR. J Clin Microbiol 2007, 45:303-305.
66. Gerrits M.M., Berning M., Van Vliet A.H., et al. Effects of 16S rRNA gene mutations on tetracycline resistance in Helicobacter pylori. Antimicrob Agents Chemother 2003, 47:2984-2986.
67. Trieber C.A., Taylor D.E. Mutations in the 16S rRNA genes of Helicobacter pylori mediate resistance to tetracycline. J Bacteriol 2002, 184:2131-2140.
68. Dailidiene D., Bertoli M.T., Miciuleviciene J., et al. Emergence of tetracycline resistance in Helicobacter pylori: multiple mutational changes in 16S ribosomal DNA and other genetic loci. Antimicrob Agents Chemother 2002, 46:3940-3946.
69. Nonaka L., Connell S.R., Taylor D.E. 16S rRNA mutations that confer tetracycline resistance in Helicobacter pylori decrease drug binding in Escherichia coli ribosomes. J Bacteriol 2005, 187:3708-3712.
70. Wu J.Y., Kim J.J., Reddy R., et al. Tetracycline-resistant clinical Helicobacter pylori isolates with and without mutations in 16S rRNA-encoding genes. Antimicrob Agents Chemother 2005, 49:578-583.
71. Glocker E., Berning M., Gerrits M.M., et al. Real-time PCR screening for 16S rRNA mutations associated with resistance to tetracycline in Helicobacter pylori. Antimicrob Agents Chemother 2005, 49:3166-3170.
72. Lawson A.J., Elviss N.C., Owen R.J. Real-time PCR detection and frequency of 16S rDNA mutations associated with resistance and reduced susceptibility to tetracycline in Helicobacter pylori from England and Wales. J Antimicrob Chemother 2005, 56:282-286.
73. Ribeiro M.L., Gerrits M.M., Benvengo Y.H., et al. Detection of high-level tetracycline resistance in clinical isolates of Helicobacter pylori using PCR-RFLP. FEMS Immunol Med Microbiol 2004, 40:57-61.
74. Toledo H., Lopez-Solis R. Tetracycline resistance in Chilean clinical isolates of Helicobacter pylori. J Antimicrob Chemother 2010, 65:470-473.
75. Heep M., Beck D., Bayerdorffer E., et al. Rifampin and rifabutin resistance mechanism in Helicobacter pylori. Antimicrob Agents Chemother 1999, 43:1497-1499.
76. Qureshi N.N., Morikis D., Schiller N.L. Contribution of specific amino acid changes in penicillin binding protein 1 to amoxicillin resistance in clinical Helicobacter pylori isolates. Antimicrob Agents Chemother 2011, 55:101-109.
77. Hoffman P.S., Goodwin A., Johnsen J., et al. Metabolic activities of metronidazole-sensitive and -resistant strains of Helicobacter pylori: repression of pyruvate oxidoreductase and expression of isocitrate lyase activity correlate with resistance. J Bacteriol 1996, 178:4822-4829.
78. Wang G., Wilson T.J., Jiang Q., et al. Spontaneous mutations that confer antibiotic resistance in Helicobacter pylori. Antimicrob Agents Chemother 2001, 45:727-733.
79. Marais A., Bilardi C., Cantet F., et al. Characterization of the genes rdxA and frxA involved in metronidazole resistance in Helicobacter pylori. Res Microbiol 2003, 154:137-144.
80. Mendz G.L., Megraud F. Is the molecular basis of metronidazole resistance in microaerophilic organisms understood?. Trends Microbiol 2002, 10:370-375.
81. van Amsterdam K., Bart A., van der Ende A. A Helicobacter pylori TolC efflux pump confers resistance to metronidazole. Antimicrob Agents Chemother 2005, 49:1477-1482.
82. Miendje Deyi V.Y., Burette A., Bentatou Z., et al. Practical use of GenoType(R) HelicoDR, a molecular test for Helicobacter pylori detection and susceptibility testing. Diagn Microbiol Infect Dis 2011, 70:557-560.
83. Tanih N.F., Ndip R.N. Molecular detection of antibiotic resistance in South African isolates of Helicobacter pylori. Gastroenterol Res Pract 2013, 2013:259457.